European funds


2nd edition of the INNOTECH programme

 

Our company, in consortium with the Pharmaceutical Institute of Warsaw and the Jagiellonian Centre of Innovation, received funding within the 2nd edition of the Innotech programme organised by the National Centre of Research and Development.

Innotech is a programme supporting science and companies in the scope of projects carried out in various fields of science and industry.

The project „synthesis and new technology of production of drug containing 5-a reductase  inhibitor” carried out on the basis of contract no.  INNOTECH-K2/IN2/65/182982/NCBR/13 dated 11 April 2013 will be carried out between 2013 and 2015.

 

logtypy

 

logtypy (1)

 

logtypy (2)


 

Knowledge, Practice, Personnel – key to success in business

 

F1 Pharma has actively contributed to the improvement of competencies of university cadres in the commercial field, by running a project supported by the Małopolska Agency of Regional Development within the „Knowledge, Practice, Personnel – key to success in business” activity. The project run from January to June 2013.

 

logosy1 (1)

 

logosy1

 

loga


 

Initiating of innovative activity

 

Our seed capital has been provided by JCI Venture Sp. z o.o. and obtained from the resources  of the Operative Programme Innovative Economy, co-financed from EU funds and implemented by the Polish Agency for Enterprise Development.

JCI Venture Sp. z o.o. Is an investment fund engaging in life science projects during the initial phase of their development.

 

loga (2)

loga (1)

loga